Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
110 participants
INTERVENTIONAL
2019-09-11
2021-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects Of of Pursed Lip Breathing and Coordinated Breathing in Adult Patients With COPD
NCT06459843
Effects of Pursed-lip Breathing on Exercise Tolerance and Dynamic Hyperinflation in COPD
NCT01173328
Dose Response of Pursed Lip Breathing With Diaphragmatic Breathing On Pulmonary Functions in Patients With COPD
NCT04928729
Pursed-lips Breathing and Dynamic Hyperinflation
NCT02203058
Effect of Pursed Lips Breathing on Chest Wall, Mobility Diaphragmatic and Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease
NCT02424331
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy
Lung-healthy subjects, randomized lung function testing
Baseline
Lung function testing with MasterScreen™ Body, CareFusion Germany GmbH
MESH-Resistor 5
Lung funtion testing with MasterScreen™ Body, CareFusion Germany GmbH, Mouthpiece with mesh-resistor (5hPa/L) to create laminar airflow
MESH-Resistor 10
Lung funtion testing with MasterScreen™ Body, CareFusion Germany GmbH, Mouthpiece with mesh-resistor (10hPa/L) to create laminar airflow
Perforated Resistor 7
Lung function testing with MasterScreen™ Body, CareFusion Germany GmbH, Mouthpiece with perforated resistor (inside diameter 7mm) to create a turbulent airflow
Perforated Resistor 11
Lung function testing with MasterScreen™ Body, CareFusion Germany GmbH, Mouthpiece with perforated resistor (inside diameter 11mm) to create a turbulent airflow
Patient 1
COPD patients, randomized lung function testing
Baseline
Lung function testing with MasterScreen™ Body, CareFusion Germany GmbH
MESH-Resistor 5
Lung funtion testing with MasterScreen™ Body, CareFusion Germany GmbH, Mouthpiece with mesh-resistor (5hPa/L) to create laminar airflow
MESH-Resistor 10
Lung funtion testing with MasterScreen™ Body, CareFusion Germany GmbH, Mouthpiece with mesh-resistor (10hPa/L) to create laminar airflow
Patient 2
COPD patients, randomized lung function testing
Baseline
Lung function testing with MasterScreen™ Body, CareFusion Germany GmbH
Perforated Resistor 7
Lung function testing with MasterScreen™ Body, CareFusion Germany GmbH, Mouthpiece with perforated resistor (inside diameter 7mm) to create a turbulent airflow
Perforated Resistor 11
Lung function testing with MasterScreen™ Body, CareFusion Germany GmbH, Mouthpiece with perforated resistor (inside diameter 11mm) to create a turbulent airflow
Patient 3
COPD patients, randomized lung function testing
Baseline
Lung function testing with MasterScreen™ Body, CareFusion Germany GmbH
MESH-Resistor 5
Lung funtion testing with MasterScreen™ Body, CareFusion Germany GmbH, Mouthpiece with mesh-resistor (5hPa/L) to create laminar airflow
Perforated Resistor 7
Lung function testing with MasterScreen™ Body, CareFusion Germany GmbH, Mouthpiece with perforated resistor (inside diameter 7mm) to create a turbulent airflow
Patient 4
COPD patients, randomized lung function testing
Baseline
Lung function testing with MasterScreen™ Body, CareFusion Germany GmbH
MESH-Resistor 5
Lung funtion testing with MasterScreen™ Body, CareFusion Germany GmbH, Mouthpiece with mesh-resistor (5hPa/L) to create laminar airflow
Perforated Resistor 11
Lung function testing with MasterScreen™ Body, CareFusion Germany GmbH, Mouthpiece with perforated resistor (inside diameter 11mm) to create a turbulent airflow
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Baseline
Lung function testing with MasterScreen™ Body, CareFusion Germany GmbH
MESH-Resistor 5
Lung funtion testing with MasterScreen™ Body, CareFusion Germany GmbH, Mouthpiece with mesh-resistor (5hPa/L) to create laminar airflow
MESH-Resistor 10
Lung funtion testing with MasterScreen™ Body, CareFusion Germany GmbH, Mouthpiece with mesh-resistor (10hPa/L) to create laminar airflow
Perforated Resistor 7
Lung function testing with MasterScreen™ Body, CareFusion Germany GmbH, Mouthpiece with perforated resistor (inside diameter 7mm) to create a turbulent airflow
Perforated Resistor 11
Lung function testing with MasterScreen™ Body, CareFusion Germany GmbH, Mouthpiece with perforated resistor (inside diameter 11mm) to create a turbulent airflow
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* COPD (GOLD I- IV)
* Stable respiratory situation that allows routine lung funtion
* capable of communication
Healthy:
* Lung Healthy
* capable of communication
Exclusion Criteria
* Other serious acute physical illnesses that require immediate intensive medical treatment
* Acute hypercapnic decompensation with a pH \< 7.35 in the capillary BGA
* Pregnancy or Nursing
* Not able to give consent
* Not willing or able to follow the study protocol
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karl Josef Franke, PD DR med
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karl Josef Franke, PD DR med
Clinical Director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Märkische Kliniken GmbH, Klinikum Lüdenscheid
Lüdenscheid, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PLB2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.